-
(R)-4-((5R,8R,9S,10S,13R,14S,17R)-10,13-Dimethyl-3-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
-
BD1236851553-56-697%
-
¥1074.0250mg
-
N-(5-(N-(4-(1,1,1,3,3,3-Hexafluoro-2-hydroxypropan-2-yl)phenyl)sulfamoyl)-4-methylthiazol-2-yl)acetamide
-
BD6301351335106-03-098%
-
¥1259.0100mg
-
N-(4-Ethylphenyl)-3-(hydroxymethyl)-N-isobutyl-4-((tetrahydro-2H-pyran-4-yl)methoxy)benzenesulfonamide
-
BD6303241474110-21-898+%
-
¥664.050mg
-
(S)-3-(6-(3-(Difluoromethoxy)-5-fluorophenyl)-4-((3-(trifluoromethyl)phenyl)sulfonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-2-yl)-2,2-dimethylpropanoic acid
-
BD007823742055536-64-499%
-
¥3236.0100mg
-
N-(4-(1,1,1,3,3,3-Hexafluoro-2-hydroxypropan-2-yl)phenyl)thiophene-2-sulfonamide
-
BD630620293753-05-698%
-
¥1098.0100mg
-
N-(2,4-Difluorophenyl)-2-(4-(2-(4-(ethylsulfonyl)phenyl)acetamido)-2-fluorophenyl)-2-methylpropanamide
-
BD010932112068119-11-799+%
-
¥589.025mg
-
1,1,1,3,3,3-Hexafluoro-2-(2-fluoro-4'-((4-(pyridin-4-ylmethyl)piperazin-1-yl)methyl)-[1,1'-biphenyl]-4-yl)propan-2-ol
-
BD008037841359164-11-698%
-
¥886.010mg
-
2-((4-Methyl-N-(3-(trifluoromethyl)phenyl)phenyl)sulfonamido)-N-(pyridin-4-ylmethyl)acetamide
-
BD01206571529500-72-998%
-
¥1223.010mg
-
N-(4-(1,1,1,3,3,3-Hexafluoro-2-hydroxypropan-2-yl)phenyl)-4-(trifluoromethyl)benzamide
-
BD6300511246525-60-998+%
-
¥639.0100mg
-
N-(2,6-dichloro-2'-(trifluoromethoxy)-[1,1'-biphenyl]-4-yl)-2-(4-(ethylsulfonyl)phenyl)acetamide
-
BD6302651426802-50-798%
-
¥1446.050mg
-
3-Cyano-N-(3-(1-isobutyrylpiperidin-4-yl)-1-methyl-4-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)benzamide
-
BD011085231892576-58-798%
-
¥1937.025mg
-
(4R,6R,6aR,6bS,8aS,8bR,9S,10R,11aS,12aS,12bS)-6a,8a,9-Trimethyl-5'-methylene-1,3,3',4,4',5,5',6,6a,6b,6',7,8,8a,8b,9,11a,12,12a,12b-icosahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-4,6-diol
-
BD14416817676-33-498%
-
¥831.025mg
-
(S)-2-(4-Cyclopropyl-6-methylpyrimidin-5-yl)-8-(1-cyclopropylethyl)-6-(((5-(methylsulfonyl)pyridin-2-yl)methyl)amino)pteridin-7(8H)-one
-
BD014445981817773-66-298%
-
¥11200.0100mg
-
(1R,4R)-4-((R)-3-((4-fluorophenyl)sulfonyl)-3-(4-(perfluoropropan-2-yl)phenyl)pyrrolidine-1-carbonyl)cyclohexane-1-carboxylic acid
-
BD011170071801197-92-195%
-
¥
-
RORγt inverse agonist 30
-
BD015655821445901-41-698%
-
¥
-
RORγt modulator 5
-
BD015073492119042-65-698%
-
¥
-
RORγt modulator 2
-
BD016031002247083-47-098%
-
¥
-
RORγt agonist 3
-
BD015594892664106-24-398%
-
¥
-
RORγ agonist 1
-
BD014572872260631-91-098%
-
¥
-
2-((1S,3S)-3-((R)-5-((7-fluoro-1,1-dimethyl-2,3-dihydro-1H-inden-5-yl)carbamoyl)-2-methoxy-5,6,7,8-tetrahydro-1,6-naphthyridine-6-carbonyl)cyclobutyl)acetic acid
-
BD011255561854901-94-2
-
¥